Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2010
11/04/2010US20100279920 Critical care product for neonatal calves
11/04/2010US20100279333 Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
11/04/2010US20100278997 Preparation for restenosis prevention
11/04/2010US20100278945 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
11/04/2010US20100278895 Antioxidants and antimicrobial accessories including antioxidants
11/04/2010US20100278894 Antioxidants and antimicrobial accessories including antioxidants
11/04/2010US20100278885 C70-Containing Liposome, Method for Producing the Same, and Use of the Same
11/04/2010US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth
11/04/2010US20100278803 Alzheimer's Disease Diagnosis Based on Mitogen-Activated Protein Kinase Phosphorylation
11/04/2010US20100278800 Stem cell factor-like proteins and uses thereof
11/04/2010US20100278799 Composition for Improving Nutritional Status, Reducing Frequency of Fever and/or Increasing Immunocompetence of the Elderly
11/04/2010US20100278751 Radiolabeled 2-amino-4-alkyl-6-(haloalkyl)pyridine compounds and their use in diagnostic imaging
11/04/2010US20100278744 Preparation for restenosis prevention
11/04/2010US20100278733 Composition for diagnosis of amyloid-related disease
11/04/2010US20100276329 Topical glycopyrrolate formulations
11/04/2010US20100275431 Drug delivery from stents
11/04/2010CA2760630A1 Quaternary ammonium salt compounds
11/04/2010CA2760387A1 Thiophene derivative
11/04/2010CA2760048A1 Therapeutic agent for motor disorders
11/04/2010CA2760031A1 Acetone solvate crystals of trityl olmesartan medoxomil
11/04/2010CA2759859A1 Carbinol compound having heterocyclic linker
11/04/2010CA2759471A1 Heteroarylthiomethyl pyridine derivative
11/04/2010CA2759163A1 Method for producing olmesartan medoxomil
11/04/2010CA2759155A1 Antiparasitic agent for fish and method of controlling proliferation of fish parasites
11/04/2010CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/03/2010EP2246430A1 Anti-adam-15 antibodies and utilization of the same
11/03/2010EP2246344A1 Pyrimidine compounds and medicinal composition thereof
11/03/2010EP2246338A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
11/03/2010EP2246336A1 Fibrosis inhibitor
11/03/2010EP2246334A1 Medicinal composition for inhibiting amyloid- protein deposition
11/03/2010EP2246056A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
11/03/2010EP2246055A1 The use of aryl piperazine derivatives in manufacturing medicants for treating pain
11/03/2010EP2246051A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient
11/03/2010EP1556080B1 Furin inhibitors for use in the treatment of fibrosis and scarring
11/03/2010EP1499742B1 Nad(p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
11/03/2010EP1490080B1 medical use of anthocyanins extracted from black rice
11/03/2010EP1469834B1 Multi-stage oral drug controlled-release system
11/03/2010EP1406615B1 Kinase inhibitors and the use thereof
11/03/2010EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug
11/03/2010EP1268760B1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments
11/03/2010EP1242437B1 Novel stromelysin inhibitors
11/03/2010CN1812812B Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis
11/03/2010CN101878201A Fused indane compound
11/03/2010CN101878193A Bicyclic gamma-amino acid derivative
11/03/2010CN101878041A Method for producing granulated matter
11/03/2010CN101878027A Receptor targeting ligands
11/03/2010CN101874881A Chinese medicinal composition and application thereof
11/03/2010CN101874879A Chinese medicinal composition for treating osteopyrexia and preparation method thereof
11/03/2010CN101874821A Witloof and Uighur edible alkaline plant compound preparation for effectively improving acidic physique
11/03/2010CN101874807A Application of lanosterol and tuckahoe extract in treating cachexia
11/03/2010CN101550176B Fine purification method for cholic acid crude product
11/03/2010CN101102744B Skin-whitening agent
11/03/2010CN101098870B Novel fused imidazole derivative
11/02/2010USRE41911 Epothilone derivatives
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825247 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/02/2010US7825228 Bone mineralization proteins, DNA, vectors, expression systems
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7825133 a mixture of 1-(4-hydroxyphenyl)-5-methylpyridin-2-one and pharmaceutically-acceptable excipients, used foro the treatment of liver fibrosis
11/02/2010US7825129 Thieno[2,3-c] isoquinolines for use as inhibitors of PARP
11/02/2010US7825113 2-oxy-benzoxazinone derivatives for the treatment of obesity
11/02/2010US7825109 Compound capable of binding S1P receptor and pharmaceutical use thereof
11/02/2010US7825105 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
11/02/2010US7825094 the sensitivity of cells typical of various proliferative disorders to the ansamycin CNF-101 ("17-AAG") is proportional to the HER-2 levels in those cells
11/02/2010US7824913 Tissue engineering; in vitro method for inducing cells to produce an extracellular matrix; living extracellular matrix, which has tissue-like properties, can be used for testing or clinical purposes
11/02/2010US7824850 Methods of protein destabilization and uses thereof
11/02/2010US7824688 Glucan-based vaccines
11/02/2010CA2485201C Camptothecins with a modified lactone ring
11/02/2010CA2462799C Pyrimidine derivatives
11/02/2010CA2460144C Pyridinic sulfonamide derivatives, method of production and use thereof
11/02/2010CA2460121C 3-substituted-4-pyrimidone derivatives
11/02/2010CA2458740C Method of treating systemic inflammatory response syndrome
11/02/2010CA2457720C Medicine containing pyrimidine derivative
11/02/2010CA2446639C Composition for the prevention of addiction in pain management
11/02/2010CA2439784C Pyrazolopyrimidinone derivatives having pde7 inhibiting action
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2437481C The use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
11/02/2010CA2436361C Angiotensin ii antagonistic compound for use as analgesic and antiinflammatory agent
11/02/2010CA2416771C 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid for treatment of cox-2 dependent disorders
11/02/2010CA2405741C Sodium salt of an azo derivative of 5-aminosalicylic acid
11/02/2010CA2393523C Combination of cyamemazine and an atypical neuroleptic
11/02/2010CA2392621C Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
11/02/2010CA2389681C Npy y5 antagonist
11/02/2010CA2383293C Anti-infective compositions for treating disordered tissue such as cold sores
11/02/2010CA2360252C Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
11/02/2010CA2337422C Preventing airway mucus production by administration of egf-r antagonists
11/02/2010CA2336602C Companion animal therapeutic treat
11/02/2010CA2330170C Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
11/02/2010CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/02/2010CA2281049C Water-soluble pharmaceutical composition in an ionic complex and the use thereof
10/2010
10/28/2010WO2010123983A1 Compostions and methods for targeted gene therapy
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123136A1 Association of htra1 mutations and familial ischemic cerebral small-vessel disease
10/28/2010WO2010123102A1 Collagen production promoter, anti-photoaging agent, moisture-retention improvement agent, and composite for use on skin
10/28/2010WO2010123078A1 Method for predicting therapeutic effect of chemotherapy on renal cell cancer
10/28/2010WO2010123049A1 Selective ep4 receptor agonistic substance for treatment of cancer
10/28/2010WO2010123037A1 Agent for regulating composition ratio of intestinal bacterial flora
10/28/2010WO2010123018A1 Diazaspiroalkane derivative
10/28/2010WO2010123017A1 Tetrazole compound
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 1564